Anson Funds Management
CELZ icon

Anson Funds Management’s Creative Medical Technology CELZ Stock Holding History

Anson Funds Management’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-105,549
Closed -$153K – 159
2026
Q2 		$153K Buy
+105,549
New +$228K 0.01% 163

Other funds holding CELZ

MYDA Advisors
MYDA Advisors Woodmere, New York $900M AUM 46.04% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Global Retirement Partners
Global Retirement Partners San Rafael, California $7.1B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Anson Funds Management's CELZ Position: Q3 2026 in Review

Anson Funds Management sold out of Creative Medical Technology (CELZ) in Q3 2026, closing a stake of 105,549 shares — an estimated $153K sold.

Anson Funds Management first reported a position in CELZ in Q2 2026 and held it in 1 quarter. The position peaked at $153K in Q2 2026. 15 funds tracked by Wall St. Rank hold CELZ as of Q3 2026.

  • Anson Funds Management reported no remaining Creative Medical Technology position as of Q3 2026 after selling out during the quarter.
  • Anson Funds Management sold 105,549 Creative Medical Technology shares in Q3 2026, an estimated $153K.
  • Anson Funds Management first reported a position in Creative Medical Technology in Q2 2026 and held it in 1 quarter.
  • Anson Funds Management's Creative Medical Technology position peaked at $153K in Q2 2026.
  • 15 funds tracked by Wall St. Rank held Creative Medical Technology as of Q3 2026.

Based on Anson Funds Management's 13F filing for Q3 2026, filed 13 Nov 2026.